iRhythm Technologies, Inc.

BIT:1IRTC Stock Report

Market Cap: €4.6b

iRhythm Technologies Management

Management criteria checks 3/4

iRhythm Technologies' CEO is Quentin Blackford, appointed in Oct 2021, has a tenure of 3.83 years. total yearly compensation is $9.34M, comprised of 8% salary and 92% bonuses, including company stock and options. directly owns 0.34% of the company’s shares, worth €15.41M. The average tenure of the management team and the board of directors is 2.6 years and 3.8 years respectively.

Key information

Quentin Blackford

Chief executive officer

US$9.3m

Total compensation

CEO salary percentage7.96%
CEO tenure3.8yrs
CEO ownership0.3%
Management average tenure2.6yrs
Board average tenure3.8yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Quentin Blackford's remuneration changed compared to iRhythm Technologies's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2025n/an/a

-US$92m

Mar 31 2025n/an/a

-US$98m

Dec 31 2024US$9mUS$744k

-US$113m

Sep 30 2024n/an/a

-US$151m

Jun 30 2024n/an/a

-US$132m

Mar 31 2024n/an/a

-US$130m

Dec 31 2023US$17mUS$677k

-US$123m

Sep 30 2023n/an/a

-US$105m

Jun 30 2023n/an/a

-US$99m

Mar 31 2023n/an/a

-US$105m

Dec 31 2022US$8mUS$650k

-US$116m

Sep 30 2022n/an/a

-US$128m

Jun 30 2022n/an/a

-US$131m

Mar 31 2022n/an/a

-US$124m

Dec 31 2021US$10mUS$163k

-US$101m

Compensation vs Market: Quentin's total compensation ($USD9.34M) is above average for companies of similar size in the Italian market ($USD2.01M).

Compensation vs Earnings: Quentin's compensation has been consistent with company performance over the past year.

CEO

Quentin Blackford (46 yo)

3.8yrs
Tenure
US$9,343,903
Compensation

Mr. Quentin S. Blackford is Director of Alphatec Spine, Inc. Mr. Blackford was Independent Director of Alphatec Spine, Inc. from October 2017. Mr. Blackford joined the Alphatec Spine, Inc. on October 02, 2...

Leadership Team

NamePositionTenureCompensationOwnership
Quentin Blackford
President3.8yrsUS$9.34m0.34%
€ 15.4m
Daniel Wilson
CFO & Principal Financial Officer1yrUS$2.54m0.13%
€ 5.8m
Minang Turakhia
Chief Medical & Scientific Officer and Executive VP of Product Innovation3.3yrsUS$3.32m0.048%
€ 2.2m
Patrick Murphy
Chief Business & Legal Officer3.7yrsUS$3.00m0.092%
€ 4.2m
Chad Patterson
Chief Commercial Officer3.1yrsUS$3.64m0.040%
€ 1.9m
Mervin Smith
Executive Vice President of Business Operations2.1yrsno data0.0045%
€ 206.2k
Marc Rosenbaum
Senior VP of Finance & Chief Accounting Officer2yrsno data0.0090%
€ 412.0k
Brian Lawrence
Executive VP & CTOless than a yearno datano data
Sean Freeman
Executive Vice President of Strategy & Corporate Developmentless than a yearno datano data
Sumi Shrishrimal
Executive VP & Chief Risk Officer3.3yrsno data0.11%
€ 5.0m
Stephanie Zhadkevich
Director of Investor Relationsno datano datano data
2.6yrs
Average Tenure
46yo
Average Age

Experienced Management: 1IRTC's management team is considered experienced (2.6 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Quentin Blackford
President3.6yrsUS$9.34m0.34%
€ 15.4m
Michael Mirro
Medical Director & Member of Scientific Advisory Boardno datano datano data
Karen McGinnis
Directorless than a yearno datano data
Bruce Bodaken
Independent Director8.1yrsUS$227.71k0.035%
€ 1.6m
Abhijit Talwalkar
Independent Chairman9.3yrsUS$272.21k0.059%
€ 2.7m
R. Mead
Medical Director & Member of Scientific Advisory Boardno datano datano data
James Quinn
Member of Scientific Advisory Boardno datano datano data
Cathleen Noel Merz
Independent Director7.3yrsUS$217.21k0.024%
€ 1.1m
Mehdi Razavi
Medical Director & Member of Scientific Advisory Boardno datano datano data
Karen Ling
Independent Director3.8yrsUS$224.71k0.026%
€ 1.2m
Brian Yoor
Independent Director2.2yrsUS$223.48k0.0083%
€ 379.0k
Jay Alexander
Medical Director & Member of Scientific Advisory Boardno datano datano data
3.8yrs
Average Tenure
61.5yo
Average Age

Experienced Board: 1IRTC's board of directors are considered experienced (3.8 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/08/04 21:20
End of Day Share Price 2025/08/04 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

iRhythm Technologies, Inc. is covered by 24 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Michael PolarkBaird
David RescottBaird
Joanne WuenschBMO Capital Markets Equity Research